Skip to main content

Lamond David

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Lamond David as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

QNCX Quince Therapeutics, Inc.

Director6 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 14, 2023 (view filing)Dec 12-142 daysLamond DavidDirectorPPurchase+45.6K$1.02+$46.5K+2.0%2.35M after3 lots
Dec 14, 2023 (view filing)Dec 122 daysLamond DavidDirectorPPurchase+22.3K$1.02+$22.8K+1.0%2.30M after
Dec 7, 2023 (view filing)Dec 5-72 daysLamond DavidDirectorPPurchase+57.4K$1.01+$58.1K+2.6%2.28M after3 lots
Dec 1, 2023 (view filing)Nov 29-Dec 12 daysLamond DavidDirectorPPurchase+43.1K$0.94+$40.5K+2.0%2.22M after3 lots
Aug 31, 2023 (view filing)Aug 30-311 dayLamond DavidDirectorPPurchase+82.1K$1.32+$107.9K+3.9%2.18M after2 lots
Aug 17, 2023 (view filing)Aug 15-172 daysLamond DavidDirectorPPurchase+250.0K$1.30+$325.7K+13.5%2.10M after3 lots

AMTI Applied Molecular Transport Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 23, 2022 (view filing)May 20-233 daysLamond DavidDirectorPPurchase+66.5K$3.17+$210.8K+6.6%1.08M after2 lots